Market Analysis, Personal Finance Tips & Economic Insights
Popular



Key Points
Small- and micro-cap stocks are more volatile, presenting opportunities and risks.
Hovnanian’s stock price surge is cited as an example of volatility working in investors’ favor.
Emphasis on the importance of thorough research before investing in micro-cap stocks.
5 stocks we like better than Eastman Chemical
When it comes to investing in micro-cap stocks, it can sometimes be a real challenge to distinguish the potential winners from those that might not offer much near-term upside. However, a great way to uncover some possible leads is at conferences where investors can meet with the management teams of these smaller companies.
As the largest independent event for micro-cap companies, the annual Microcap Conference often yields some interesting ideas. This year’s conference edition wrapped up earlier this month with presentations from over 75 different micro-cap companies.Get Eastman Chemical alerts:Sign Up
In general, micro-cap stocks are those of companies with a market capitalization of less than $300 million. Despite their smaller size, some micro-cap companies have the potential to punch above their weight within their respective industries, so here are some of the more interesting stock ideas from the 2024 Microcap Conference.
Eden Research
U.K.-based Eden Research LON: EDEN specializes in plastic-free, sustainable solutions for crop protection, animal health and consumer products, with a focus on sustainable biopesticides and plastic-free encapsulation technology. The company’s vision is to become a “global leader in sustainable crop protection.”
Eden focuses on sustainably protecting high-value crops, improving yields, and marketability. So far, the company has commercialized two of its products. The first product, Mevalone, is a bio-fungicide sold in 14 European countries, the U.S., Australia and Kenya.
Eden Research partnered with Eastman Chemical NYSE: EMN to commercialize its second product, a nematicide called Cedroz. The companies are targeting 29 countries, and so far, 11 have granted full approval to the product, including the U.S., Mexico, Spain and Italy.
Genie Energy
With its market cap of $498.7 million, Genie Energy NYSE: GNE is technically a small-cap stock. The company is a retail provider of both green and conventional electricity and natural-gas supply. It provides both on-site and community solar-energy solutions, focusing on deregulated markets within the U.S.Genie Energy also works with commercial enterprises, utility-scale solar developers and community solar developers on the planning, financing, design, construction, and operation of solar projects aimed at maximizing the value of solar generation.
Through its retail segment, the company serves homeowners and small, medium, and large businesses, supplying electricity from either renewable or conventional sources. Genie Energy also provides carbon-offset natural gas and conventional natural gas supply and end-to-end energy advisory services.
The company’s Renewable Solutions division serves community solar programs, partnering with developers to finance their projects, acquire customers and manage the project. Genie Energy also enables commercial enterprises to leverage on-site solar generation to reduce their energy costs.
Hovnanian Enterprises

Hovnanian is a national homebuilder that designs, constructs and markets a variety of for-sale housing in nearly 130 residential communities in 13 different states. In fiscal 2023, the company generated $2.76 billion in total revenues on 5,473 home deliveries, making it one of the largest homebuilders in the U.S.
Hovnanian has operations in Arizona, California, Delaware, Florida, George, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, Texas, Virginia, Washington, D.C., and West Virginia. Its homes are marketed and sold under the trade name K. Hovnanian Homes.
Investing in micro- and small-cap stocks
Small- and micro-cap stocks are typically more volatile than large-cap names, although that can be both good and bad. The surge in Hovnanian’s stock price that took it from micro-cap to small-cap status in a matter of months is one example of how that volatility can work in investors’ favor if they choose wisely.
However, with the possibility of sizable returns also comes a chance for significant risk. Unfortunately, it can be challenging to find public information on some micro-cap stocks. Nonetheless, many of the best companies voluntarily disclose pertinent information to investors even if their small size prevents them from being required to do so.
Additionally, smaller companies that trade on major exchanges may be required to disclose more information. Of course, it’s always a good idea to research a company thoroughly before investing in it.Before you consider Eastman Chemical, you’ll want to hear this.MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Eastman Chemical wasn’t on the list.While Eastman Chemical currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report

Share this article
Shareable URL
Prev Post
Next Post
Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
3M NYSE: MMM is turning a corner. The company wasn’t hurt by ailing business so much as lawsuits related to…
Key Points Cirrus Logic’s shares lagged behind those of its bigger peers last year, but that’s set…
An apparent tailwind hit yesterday’s value stocks, a new development seen in the declining shares of…
  Upgrade NowThis premium article is available to MarketBeat All Access subscribers only. Log in to your account…